
Takeda Pharmaceutical Co Ltd
NYSE:TAK

Intrinsic Value
The intrinsic value of one
TAK
stock under the Base Case scenario is
17.88
USD.
Compared to the current market price of 14.88 USD,
Takeda Pharmaceutical Co Ltd
is
Undervalued by 17%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Takeda Pharmaceutical Co Ltd
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Takeda Pharmaceutical Co Ltd
Balance Sheet Decomposition
Takeda Pharmaceutical Co Ltd
Current Assets | 2.5T |
Cash & Short-Term Investments | 405.6B |
Receivables | 725.3B |
Other Current Assets | 1.4T |
Non-Current Assets | 11.7T |
Long-Term Investments | 361.9B |
PP&E | 2T |
Intangibles | 9T |
Other Non-Current Assets | 441B |
Free Cash Flow Analysis
Takeda Pharmaceutical Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Takeda Pharmaceutical Co Ltd
Revenue
|
4.6T
JPY
|
Cost of Revenue
|
-1.6T
JPY
|
Gross Profit
|
3T
JPY
|
Operating Expenses
|
-2.7T
JPY
|
Operating Income
|
342.6B
JPY
|
Other Expenses
|
-234.7B
JPY
|
Net Income
|
107.9B
JPY
|
TAK Profitability Score
Profitability Due Diligence
Takeda Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Score
Takeda Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
TAK Solvency Score
Solvency Due Diligence
Takeda Pharmaceutical Co Ltd's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Score
Takeda Pharmaceutical Co Ltd's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TAK Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
TAK
is 17.32 USD
with a low forecast of 15.36 USD and a high forecast of 20.94 USD.
Dividends
Current shareholder yield for Takeda Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TAK
stock under the Base Case scenario is
17.88
USD.
Compared to the current market price of 14.88 USD,
Takeda Pharmaceutical Co Ltd
is
Undervalued by 17%.